ALPHA TEKNOVA, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
ALPHA TEKNOVA, INC. (TKNO) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$3.61 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-02
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$3.61M.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$5.63M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$3.61M 10-K · filed 2026-03-02 |
| 2024-12-31 | -$5.63M 10-K · filed 2026-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |